Skip to search formSkip to main contentSkip to account menu

ASL 8052

Known as: ASL-8052 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Esmolol hydrochlorideesmolol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1984
1984
Beta-blocking and hemodynamic effects of ASL-8052.
The hemodynamic and cardiac beta-blocking effects of ASL-8052 (esmolol), an ultrashort-acting beta-blocker, were examined in… 
Highly Cited
1983
Highly Cited
1983
Pharmacology of ASL‐8052, a Novel β-Adrenergic Receptor Antagonist with an Ultrashort Duration of Action
Summary ASL-8052, a novel β-adrenergic receptor antagonist, was studied in isolated guinea pig cardiac and tracheal tissues, in… 
1983
1983
Cardiovascular pharmacology of ASL-8052, an ultra-short acting beta blocker.
ASL-8052, a novel ultra-short acting beta receptor blocking agent, was infused i.v. and its cardiovascular effects were… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)